Global /China /Healthcare /Biotechnology /688163

Shanghai Serum Bio-Technology Co., Ltd.

688163

• SSE: 688163 • Delayed

35.20CNY -0.1%

5.20 USD

As of 15 June 2026, Shanghai Serum Bio-Technology Co., Ltd. has a market cap of $562.98M USD, ranking #14341 globally and #4427 in China. It ranks #1276 in the Healthcare sector, and #238 in the Biotechnology industry.

Global Rank

14341

Country Rank

4427

Sector Rank

1276

Industry Rank

238

Key Stats

Market Cap

$562.98MUSD

3.81B CNY

Enterprise Value

$451.42MUSD

3.05B CNY

Revenue (TTM)

$29.17MUSD

197.68M CNY

EBITDA (TTM)

$10.47MUSD

70.83M CNY

Net Income (TTM)

$7.17MUSD

48.6M CNY

EBITDA Margin

36%

Profit Margin

25%

PE Ratio

65.8

PS Ratio

19.3

PB Ratio

3.4

EV/EBITDA

42.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Tiejiong Fan open_in_new

Employees

324

Founded

1999

Website

serum-china.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.1%	-13%	39%	44%	48%	62%	107%	53%	-9.9%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688163 上海赛伦生物技术股份有限公司 Class A ISIN: CNE1000059X8 Shares Out.: Shares Outstanding: 108.22M¹ Shares Float: 108.208M² TV: TradingView: SSE: 688163 SA: Stock Analysis: SHA: 688163 YF: Yahoo Finance: 688163.SS GF: Google Finance: SHA: 688163 BA: Barron's: 688163 MS: Morningstar: XSHG: 688163	35.20 CNY	TV: TradingView: SSE: 688163 SA: Stock Analysis: SHA: 688163 YF: Yahoo Finance: 688163.SS GF: Google Finance: SHA: 688163 BA: Barron's: 688163 MS: Morningstar: XSHG: 688163

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shanghai Serum Bio-Technology Co., Ltd.

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.44B 136.71B HKD 3K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 2K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.0B 54.23B CNY 1K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.33B 49.69B CNY 1K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 1K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 1K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 32K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 28K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 8K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 8K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 7K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 7K%	37.2	Switzerland

chevron_leftBack